CHIPMOS Technologies to Distribute NT$1.23/Share from Capital Surplus; No 2025 Earnings Dividends
Summary
CHIPMOS Technologies announced its 2026 Annual Shareholders' Meeting agenda, including a proposal for a NT$1.23 per share cash distribution from capital surplus, despite not distributing dividends from 2025 earnings due to a profit decline.
Key Events
-
Annual Shareholders' Meeting Scheduled
The company will hold its 2026 Annual Shareholders' Meeting on May 26, 2026, with an ADS voting deadline of May 18, 2026.
-
No 2025 Earnings Dividends Proposed
The Board proposes not to distribute dividends from the fiscal year 2025 earnings, following a significant decline in net profit.
-
Significant Capital Surplus Distribution
A cash distribution of NT$1.23 per share from capital surplus is proposed, totaling approximately NT$860.98 million (equivalent to approximately $26.9 million USD), representing a notable return of capital to shareholders.
-
2025 Financial Performance Confirmed
The filing includes the 2025 business report and financial statements, showing consolidated revenue up 5.5% to NT$23.93 billion, but profit attributable to equity holders declined to NT$0.50 billion (NT$0.70 EPS) from NT$1.42 billion (NT$1.95 EPS) in 2024.
Analysis
This 6-K provides the formal notice and agenda for CHIPMOS Technologies' 2026 Annual Shareholders' Meeting. Key proposals include the adoption of the 2025 business report and financial statements, which confirm a significant decline in net profit and earnings per share compared to 2024, as previously reported in the 20-F. The company proposes not to distribute dividends from 2025 earnings. However, it plans a substantial cash distribution of NT$1.23 per share from capital surplus, representing a significant return of capital to shareholders. This mixed approach reflects the company's weaker 2025 performance while still providing shareholder returns.
At the time of this filing, IMOS was trading at $46.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $15.06 to $51.08. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.